You are here: Industry Insights > deaL

News List

Boehringer Ingelheim chops 295 jobs in France but vows $380M in animal health investments fiercepharma
December 12, 2018
When German pharma Boehringer Ingelheim completed a $12.5 billion asset swap with France’s Sanofi in 2016, BI traded its consumer health business for Sanofi’s veterinary unit and agreed
US court affirms decision to permit Fresenius to withdraw from deal to buy Akorn firstwordpharma
December 10, 2018
The Delaware Supreme Court on Friday upheld a lower court ruling permitting Fresenius Kabi to terminate its agreement to acquire Akorn for more than $4 billion. Shares in the latter drugmaker were down as much as 37 percent on the news.
Takeda sets target date to close $62B Shire deal biospectrum
November 14, 2018
The deal would be the largest-ever overseas acquisition by a Japanese company.
AstraZeneca's rummage sale continues with $350M deal, its second in a week fiercepharma
November 07, 2018
Only a week after AstraZeneca worked up a deal to sell some Nexium and Vimovo rights for hundreds of millions of dollars, the company is back at it with an agreement that’ll generate $350 million in cash.
Lilly signs licensing and research deal with Dicerna Pharmaceuticals pharmaceutical-technology
October 31, 2018
Eli Lilly has entered a global licensing and research alliance with Dicerna Pharmaceuticals to identify, develop and commercialise potential therapies for cardio-metabolic conditions, neurodegeneration and pain.
Medpacto inks deal with AstraZeneca biospectrumasia
August 03, 2018
Under the terms of the agreement, MedPacto and AstraZeneca will collaborate on a non-exclusive basis to evaluate the combination of the two drugs in NSCLC
Otsuka snaps up Visterra in $430 million deal pharmafile
July 17, 2018
Otsuka Pharmaceutical has announced it has reached a definitive, board-approved agreement with Visterra to acquire the latter company in an all-cash transaction to the value of $430 million.
Merck inks deal with China's Xian Janssen for type 2 diabetes drug biospectrumasia
July 16, 2018
China has more than 114 million people living with diabetes, the largest number of any country in the world
Morphotek inks license deal with BlissBio biospectrumasia
April 11, 2018
BlissBio has an exclusivity option to expand the territory beyond China to the global market and to develop therapeutic ADCs to two additional undisclosed oncology targets.
Pharma, medical and biotech witness 290 deals worth $89.9 bn in second quarter: Report expressbpd
August 07, 2017
Mergermarket’s Sector Trend Report on pharma, medical and biotech sectors reveal $166 billion that changed hands across 658 deals during the first half of 2017 accounted for an 11.1 per cent market share of global M&A

Previous page 1 2 3 Next page